PMID- 36990164 OWN - NLM STAT- MEDLINE DCOM- 20230609 LR - 20230613 IS - 1879-1220 (Electronic) IS - 0960-0760 (Linking) VI - 231 DP - 2023 Jul TI - The inhibitory effect of vitamin D on myocardial homocysteine levels involves activation of Nrf2-mediated methionine synthase. PG - 106303 LID - S0960-0760(23)00058-4 [pii] LID - 10.1016/j.jsbmb.2023.106303 [doi] AB - BACKGROUND: Homocysteine (Hcy) is a synthetic amino acid containing sulfhydryl group, which is an intermediate product of the deep metabolic pathway of methionine and cysteine. The abnormal increase in fasting plasma total Hcy concentration caused by various factors is called hyperhomocysteine (HHcy). HHcy is closely relevant to the occurrence and progression of diverse cardiovascular and cerebrovascular diseases, such as coronary heart disease, hypertension and diabetes, etc. Vitamin D/vitamin D receptor (VDR) pathway is pointed out that prevent cardiovascular disease by reducing serum homocysteine levels. Our research is designed to explore the potential mechanism of vitamin D in the prevention and treatment of HHcy. METHODS AND RESULTS: The Hcy and 25(OH)D(3) levels in mouse myocardial tissue, serum or myocardial cells were detected using ELISA kits. The expression levels of VDR, Nrf2 and methionine synthase (MTR) were observed using Western blotting, immunohistochemistry and real time polymerase chain reaction (PCR). General information of the mice, including diet, water intake and body weight, was recorded. Vitamin D up-regulated the mRNA and protein expression of Nrf2 and MTR in mouse myocardial tissue and cells. CHIP assay determined that the combination of Nrf2 binding to the S1 site of the MTR promoter in cardiomyocytes using traditional PCR and real time PCR. Dual Luciferase Assay was applied to detect the transcriptional control of Nrf2 on MTR. The up-regulation effect of Nrf2 on MTR was verified by Nrf2 knockout and overexpression in cardiomyocytes. The role of Nrf2 in vitamin D inhibition of Hcy was revealed using Nrf2-knockdown HL-1 cells and Nrf2 heterozygous mice. Western blotting, real time PCR, IHC staining and ELISA showed that Nrf2 deficiency could restrain the increase in MTR expression and the decrease in Hcy level induced by vitamin D. The transcriptional activities of Nrf2/MTR were activated by vitamin D/VDR with a decrease in Hcy. CONCLUSION: Vitamin D/VDR upregulates MTR in an Nrf2-dependent manner, thereby reducing the risk of HHcy. CI - Copyright (c) 2023 Elsevier Ltd. All rights reserved. FAU - Sun, Xiaoqi AU - Sun X AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Liu, Ning AU - Liu N AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Sun, Can AU - Sun C AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Xu, Yingxi AU - Xu Y AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Ding, Ding AU - Ding D AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. FAU - Kong, Juan AU - Kong J AD - Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: kongj@cmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230328 PL - England TA - J Steroid Biochem Mol Biol JT - The Journal of steroid biochemistry and molecular biology JID - 9015483 RN - 1406-16-2 (Vitamin D) RN - 0 (NF-E2-Related Factor 2) RN - EC 2.1.1.13 (5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase) RN - 0 (Vitamins) RN - AE28F7PNPL (Methionine) SB - IM MH - Mice MH - Animals MH - *Vitamin D/pharmacology MH - *NF-E2-Related Factor 2/genetics MH - 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/genetics MH - Vitamins MH - Methionine OTO - NOTNLM OT - Homocysteine OT - Methionine synthase OT - Nrf2 OT - Vitamin D COIS- Conflict of interest All authors state that no conflict of interest. EDAT- 2023/03/30 06:00 MHDA- 2023/06/09 06:42 CRDT- 2023/03/29 19:30 PHST- 2022/09/13 00:00 [received] PHST- 2023/02/18 00:00 [revised] PHST- 2023/03/26 00:00 [accepted] PHST- 2023/06/09 06:42 [medline] PHST- 2023/03/30 06:00 [pubmed] PHST- 2023/03/29 19:30 [entrez] AID - S0960-0760(23)00058-4 [pii] AID - 10.1016/j.jsbmb.2023.106303 [doi] PST - ppublish SO - J Steroid Biochem Mol Biol. 2023 Jul;231:106303. doi: 10.1016/j.jsbmb.2023.106303. Epub 2023 Mar 28.